drugset / Trial / NCT03831880
Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
RandomizedCrossoverOpen-labelOther
Summary
This is an open label randomized 24 week crossover trial assessing the treatment burden of a weekly growth hormone injection regimen (somatrogon) compared to a daily growth hormone injection regimen (Genotropin). Approximately 90 children with growth hormone deficiency who have been stable on treatment with daily Genotropin will be enrolled.
Timeline
- Start
- 2019-02-07
- Primary completion
- 2020-08-28
- Completion
- 2020-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatrogon | Protein / enzyme biologic | 0.66 mg/kg | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | — | Subcutaneous |